Inside Therapeutics offers microfluidic-based systems for nanoparticle manufacturing, focusing on LNP-RNA vaccine development and oncology.
Inside Therapeutics has raised $1.4M in total funding. The most recent round was Seed. The last funding was announced in June 2024.
Inside Therapeutics's investors include Newfund, Skalepark.
Inside Therapeutics is headquartered in Angoulême, France.
Inside Therapeutics offers microfluidic-based systems for nanoparticle manufacturing, focusing on LNP-RNA vaccine development and oncology.
Inside Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inside Therapeutics — Funding & Investors." VCBacked, June 20, 2024, https://www.vcbacked.co/company/inside-therapeutics. Accessed October 2, 2026.
VCBacked. (2024). Inside Therapeutics — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/inside-therapeutics
{{cite web |title=Inside Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/inside-therapeutics |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated